Clinical Trials · NCT07674290

Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity

Phase
Phase 4
Recruitment status
Recruiting
Sponsor
Tom Hühne
Enrollment
200
Start date
Jan 2023
Locations
1 site, Germany
Primary endpoint
Percent change in BMI z-score
View Setmelanotide compound reference